SAN DIEGO (GenomeWeb News) — MicroRNAs are cropping up in different aspects of cancer research, according to a session at the American Association for Cancer Research annual meeting held here this week.

MicroRNAs can act as oncogenes and as tumor suppressors, and they are increasingly of interest to researchers wanting to inhibit cancer development, develop biomarkers for disease progression, and for potential use as therapeutics, among other endeavors.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: spatiotemporal study of lncRNA expression, role of extrachromosomal, circular DNAs in yeast, and more.

A European team has launched a four-year study to develop a test to gauge cervical, ovarian, uterine, or aggressive breast cancer risk in women.

As interest in personalized medicine grows, government contractors are entering the field, the Washington Post reports.

In PLOS this week: Plasmodium knowlesi population genetics, oral microbiome of infants and children, and more.